HEADER PROTEIN BINDING 05-APR-24 9BB6 TITLE BACKBONE MODIFICATION IN THE GA MODULE OF PROTEIN PAB: ACPC RESIDUES TITLE 2 AT POSITIONS 5 AND 13, BETA3 RESIDUE AT POSITION 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTOSTREPTOCOCCAL ALBUMIN-BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: FINEGOLDIA MAGNA; SOURCE 4 ORGANISM_TAXID: 1260 KEYWDS HELIX BUNDLE, DESIGNED VARIANT, PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR Y.LIN,W.S.HORNE REVDAT 1 05-JUN-24 9BB6 0 JRNL AUTH Y.LIN,W.S.HORNE JRNL TITL BACKBONE MODIFICATION IN A PROTEIN HYDROPHOBIC CORE. JRNL REF CHEMISTRY 01890 2024 JRNL REFN ISSN 0947-6539 JRNL PMID 38753977 JRNL DOI 10.1002/CHEM.202401890 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9BB6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-APR-24. REMARK 100 THE DEPOSITION ID IS D_1000283000. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283 REMARK 210 PH : 5.8 REMARK 210 IONIC STRENGTH : 1 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MM GA MODULE OF PROTEIN PAB: REMARK 210 ACPC RESIDUES AT POSITIONS 5 AND REMARK 210 13, BETA3 RESIDUE AT POSITION 9, REMARK 210 0.2 MM DSS, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H COSY; REMARK 210 2D 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, POKY, ARIA REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 BIL A 9 -74.71 2.25 REMARK 500 1 THR A 18 37.14 -141.38 REMARK 500 2 LYS A 2 31.88 -88.84 REMARK 500 2 BIL A 9 -74.21 2.14 REMARK 500 2 ALA A 29 102.89 -59.28 REMARK 500 3 BIL A 9 -72.78 3.66 REMARK 500 3 ALA A 29 93.72 -65.97 REMARK 500 4 BIL A 9 -68.87 7.70 REMARK 500 4 ALA A 29 107.30 -51.82 REMARK 500 5 BIL A 9 -71.57 0.13 REMARK 500 5 ALA A 29 98.51 -56.04 REMARK 500 6 BIL A 9 -71.92 0.83 REMARK 500 7 BIL A 9 -77.56 1.06 REMARK 500 7 THR A 18 76.00 -100.22 REMARK 500 7 ALA A 29 105.88 -55.50 REMARK 500 8 BIL A 9 -73.62 2.06 REMARK 500 8 ALA A 29 97.29 -58.01 REMARK 500 9 BIL A 9 -75.12 3.61 REMARK 500 10 ASN A 3 -54.04 71.63 REMARK 500 10 BIL A 9 -76.17 2.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 4 XCP A 5 1 142.45 REMARK 500 ALA A 8 BIL A 9 1 137.46 REMARK 500 LEU A 12 XCP A 13 1 141.21 REMARK 500 ALA A 4 XCP A 5 2 141.73 REMARK 500 ALA A 8 BIL A 9 2 137.98 REMARK 500 LEU A 12 XCP A 13 2 141.58 REMARK 500 ALA A 4 XCP A 5 3 140.17 REMARK 500 ALA A 8 BIL A 9 3 138.83 REMARK 500 LEU A 12 XCP A 13 3 141.46 REMARK 500 ALA A 4 XCP A 5 4 140.96 REMARK 500 ALA A 8 BIL A 9 4 138.00 REMARK 500 LEU A 12 XCP A 13 4 140.84 REMARK 500 ALA A 4 XCP A 5 5 140.53 REMARK 500 ALA A 8 BIL A 9 5 137.06 REMARK 500 LEU A 12 XCP A 13 5 141.42 REMARK 500 ALA A 4 XCP A 5 6 140.75 REMARK 500 ALA A 8 BIL A 9 6 137.80 REMARK 500 LEU A 12 XCP A 13 6 141.45 REMARK 500 ALA A 4 XCP A 5 7 141.28 REMARK 500 ALA A 8 BIL A 9 7 136.79 REMARK 500 LEU A 12 XCP A 13 7 141.84 REMARK 500 ALA A 4 XCP A 5 8 140.67 REMARK 500 ALA A 8 BIL A 9 8 137.49 REMARK 500 LEU A 12 XCP A 13 8 141.17 REMARK 500 ALA A 4 XCP A 5 9 142.15 REMARK 500 ALA A 8 BIL A 9 9 137.31 REMARK 500 LEU A 12 XCP A 13 9 141.72 REMARK 500 ALA A 4 XCP A 5 10 141.36 REMARK 500 ALA A 8 BIL A 9 10 137.15 REMARK 500 LEU A 12 XCP A 13 10 142.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 31162 RELATED DB: BMRB REMARK 900 BACKBONE MODIFICATION IN THE GA MODULE OF PROTEIN PAB: ACPC REMARK 900 RESIDUES AT POSITIONS 5 AND 13, BETA3 RESIDUE AT POSITION 9 DBREF 9BB6 A 1 47 UNP Q51911 PAB_FINMA 219 265 SEQADV 9BB6 XCP A 5 UNP Q51911 LYS 223 ENGINEERED MUTATION SEQADV 9BB6 BIL A 9 UNP Q51911 ILE 227 ENGINEERED MUTATION SEQADV 9BB6 XCP A 13 UNP Q51911 LYS 231 ENGINEERED MUTATION SEQADV 9BB6 NH2 A 48 UNP Q51911 AMIDATION SEQRES 1 A 48 LEU LYS ASN ALA XCP GLU ASP ALA BIL ALA GLU LEU XCP SEQRES 2 A 48 LYS ALA GLY ILE THR SER ASP PHE TYR PHE ASN ALA ILE SEQRES 3 A 48 ASN LYS ALA LYS THR VAL GLU GLU VAL ASN ALA LEU LYS SEQRES 4 A 48 ASN GLU ILE LEU LYS ALA HIS ALA NH2 HET XCP A 5 17 HET BIL A 9 22 HET XCP A 13 17 HET NH2 A 48 3 HETNAM XCP (1S,2S)-2-AMINOCYCLOPENTANECARBOXYLIC ACID HETNAM BIL (3R,4S)-3-AMINO-4-METHYLHEXANOIC ACID HETNAM NH2 AMINO GROUP HETSYN BIL (R,S)-BETA-3-HOMOISOLEUCINE FORMUL 1 XCP 2(C6 H11 N O2) FORMUL 1 BIL C7 H15 N O2 FORMUL 1 NH2 H2 N HELIX 1 AA1 ASN A 3 GLY A 16 1 14 HELIX 2 AA2 SER A 19 ALA A 29 1 11 HELIX 3 AA3 THR A 31 HIS A 46 1 16 LINK C ALA A 4 N XCP A 5 1555 1555 1.32 LINK C XCP A 5 N GLU A 6 1555 1555 1.33 LINK C ALA A 8 N BIL A 9 1555 1555 1.32 LINK C BIL A 9 N ALA A 10 1555 1555 1.33 LINK C LEU A 12 N XCP A 13 1555 1555 1.33 LINK C XCP A 13 N LYS A 14 1555 1555 1.33 LINK C ALA A 47 N NH2 A 48 1555 1555 1.32 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1